Literature DB >> 12738658

Anti-hepatitis A virus immunoglobulin M antibodies in urine samples for rapid diagnosis of outbreaks.

Licel de los Angeles Rodríguez Lay1, Osmany Larralde Díaz, Raiza Martínez Casanueva, Aidonis Gutiérrez Moreno.   

Abstract

The main goal of this study was to test the feasibility of using urine for diagnosing hepatitis A virus (HAV) infections. A correlation of 90.78% between the test results of urine and serum samples was obtained. Four outbreaks of hepatitis A were confirmed by testing only urine samples. The levels of anti-HAV immunoglobulin M (IgM) antibodies in urine samples remained stable during 6 months of storage at -70 degrees C but decreased when the samples were stored at 4 degrees C. The results of tests of samples obtained 2 and 6 months after infection suggested that IgM levels decline more rapidly in urine than in serum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738658      PMCID: PMC154950          DOI: 10.1128/cdli.10.3.492-494.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  HCV antibodies in saliva and urine.

Authors:  S Elsana; E Sikuler; A Yaari; Y Shemer-Avni; M Abu-Shakra; D Buskila; P Katzman; L Naggan; M Margalith
Journal:  J Med Virol       Date:  1998-05       Impact factor: 2.327

2.  Preliminary report: accurate assays for anti-HIV in urine.

Authors:  J A Connell; J V Parry; P P Mortimer; R J Duncan; K A McLean; A M Johnson; M H Hambling; J Barbara; C P Farrington
Journal:  Lancet       Date:  1990-06-09       Impact factor: 79.321

3.  Urinary protein excretion in normal individuals: diurnal changes, influence of orthostasis and relationship to the renin-angiotensin system.

Authors:  B A van Acker; M K Stroomer; M A Gosselink; G C Koomen; M G Koopman; L Arisz
Journal:  Contrib Nephrol       Date:  1993       Impact factor: 1.580

4.  Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection.

Authors:  S Takahashi; F Machikawa; A Noda; T Oda; T Tachikawa
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways.

Authors:  J Tencer; I M Frick; B W Oquist; P Alm; B Rippe
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  Urine samples as a possible alternative to serum for human immunodeficiency virus antibody screening.

Authors:  P Martínez; R O Lejarazu; J M Eiros; J D Benito; A Rodríguez-Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

Review 7.  Clinical manifestations and diagnosis of hepatitis A virus infection.

Authors:  R S Koff
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

8.  The detection in urine specimens of IgG and IgM antibodies to hepatitis A and hepatitis B core antigens.

Authors:  K R Perry; J V Parry; E M Vandervelde; P P Mortimer
Journal:  J Med Virol       Date:  1992-12       Impact factor: 2.327

9.  Evaluation of urine as a clinical specimen for diagnosis of hepatitis a.

Authors:  Madhuri S Joshi; Shobha D Chitambar; Vidya A Arankalle; Mandeep S Chadha
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

10.  [Development and evaluation of an ELISA for the detection of IgM antibodies against the hepatitis A virus].

Authors:  L Rodríguez Lay; P Más Lago; A Balmaseda; M M Comellas; G Delgado; R Palomera
Journal:  Rev Cubana Med Trop       Date:  1994
View more
  2 in total

Review 1.  Urinary immunoglobulins in viral diagnosis: An overview.

Authors:  Sreelekshmy Mohandas; Sudeep Balan; Devendra T Mourya
Journal:  Indian J Med Res       Date:  2022-01       Impact factor: 5.274

2.  Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.

Authors:  Simon F Dufresne; Kausik Datta; Xinming Li; Ekaterina Dadachova; Janet F Staab; Thomas F Patterson; Marta Feldmesser; Kieren A Marr
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.